2164-5515

Human Vaccines & Immunotherapeutics

Informa UK (Taylor & Francis)

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 7107 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact7107 DOIs
2

Attach ORCID iDs across 4193 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact4193 DOIs
3

Add license metadata to 3696 records

License metadata tells indexers and readers how each article may be reused.

High impact3696 DOIs

DOIs for this ISSN

Showing the top 5 of 7106 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Vaccine hesitancy (10.4161/hv.24657)
Abstract ORCID License
246.33 1924
2 Social media and vaccine hesitancy: new updates for the era… (10.1080/21645515.2020.1780846)
Abstract ORCID License
223.23 946
3 Measuring trust in vaccination: A systematic review (10.1080/21645515.2018.1459252)
Abstract ORCID License
209.74 625
4 Pembrolizumab (Keytruda) (10.1080/21645515.2016.1199310)
Abstract ORCID License
197.59 430
5 Advances in aluminum hydroxide-based adjuvant research and i… (10.1080/21645515.2014.1004026)
Abstract ORCID License
193.05 374
6 The rationale for quadrivalent influenza vaccines (10.4161/hv.8.1.17623)
Abstract ORCID License
189.67 337
7 Talimogene laherparepvec: First in class oncolytic virothera… (10.1080/21645515.2017.1412896)
Abstract ORCID License
186.22 303
8 Tocilizumab (Actemra) (10.1080/21645515.2017.1316909)
Abstract ORCID License
184.79 290
9 Mechanisms and pathways of innate immune activation and regu… (10.4161/21645515.2014.979640)
Abstract ORCID License
184.34 286
10 Provider communication about HPV vaccination: A systematic r… (10.1080/21645515.2015.1129090)
Abstract ORCID License
183.88 282
11 Pre-existing immunity against Ad vectors (10.4161/hv.29594)
Abstract ORCID License
181.50 262
12 Immunization with inactivated Middle East Respiratory Syndro… (10.1080/21645515.2016.1177688)
Abstract ORCID License
181.25 260
13 Japanese encephalitis (10.4161/hv.26902)
Abstract ORCID License
180.23 252
14 Transforming growth factor-β: A therapeutic target for cance… (10.1080/21645515.2017.1327107)
Abstract ORCID License
179.71 248
15 DNA vaccine for cancer immunotherapy (10.4161/21645515.2014.980686)
Abstract ORCID License
179.71 248
16 Polymeric nanoparticles (10.4161/hv.26796)
Abstract ORCID License
178.92 242
17 Protein carriers of conjugate vaccines: Characteristics, dev… (10.4161/hv.26109)
Abstract ORCID License
178.24 237
18 Disparities in HPV vaccination rates and HPV prevalence in t… (10.1080/21645515.2018.1512453)
Abstract ORCID License
177.83 234
19 Sustained efficacy, immunogenicity, and safety of the HPV-16… (10.4161/hv.29532)
Abstract ORCID License
176.41 224
20 Phage display—A powerful technique for immunotherapy (10.4161/hv.21703)
Abstract ORCID License
176.27 223
21 Peptide/protein vaccine delivery system based on PLGA partic… (10.1080/21645515.2015.1102804)
Abstract ORCID License
175.08 215
22 Advancements in DNA vaccine vectors, non-mechanical delivery… (10.1080/21645515.2017.1330236)
Abstract ORCID License
174.93 214
23 The rise (and fall?) of parental vaccine hesitancy (10.4161/hv.25085)
Abstract ORCID License
174.93 214
24 Epidemiology of vaccine hesitancy in the United States (10.4161/hv.27243)
Abstract ORCID License
174.17 209
25 A novel, disruptive vaccination technology (10.4161/hv.25181)
Abstract ORCID License
174.01 208
26 Story and science (10.4161/hv.24828)
Abstract ORCID License
173.85 207
27 Recent advances of oncolytic virus in cancer therapy (10.1080/21645515.2020.1723363)
Abstract ORCID License
173.06 202
28 Recent progress in adjuvant discovery for peptide-based subu… (10.4161/hv.27332)
Abstract ORCID License
173.06 202
29 Correlates of protection to influenza virus, where do we go… (10.4161/hv.22908)
Abstract ORCID License
172.08 196
30 Vaccines against meningococcal serogroup B disease containin… (10.4161/hv.24129)
Abstract ORCID License
171.75 194
31 Immunology and efficacy of MF59-adjuvanted vaccines (10.1080/21645515.2018.1495301)
Abstract ORCID License
170.73 188
32 Vaccines against invasive<i>Salmonella</i>disease (10.4161/hv.29054)
Abstract ORCID License
170.39 186
33 Epidemiology of tick-borne encephalitis (TBE) in Europe and… (10.4161/hv.23802)
Abstract ORCID License
169.33 180
34 Investigating Italian parents' vaccine hesitancy: A cross-se… (10.1080/21645515.2018.1463943)
Abstract ORCID License
168.96 178
35 Community pharmacies as sites of adult vaccination: A system… (10.1080/21645515.2016.1215393)
Abstract ORCID License
168.78 177
36 Effectiveness of interventions that apply new media to impro… (10.4161/hv.34313)
Abstract ORCID License
168.41 175
37 Comparison of HDAC inhibitors in clinical development (10.4161/hv.23800)
Abstract ORCID License
167.85 172
38 Immune responses after live attenuated influenza vaccination (10.1080/21645515.2017.1377376)
Abstract ORCID License
167.66 171
39 H3N2 influenza viruses in humans: Viral mechanisms, evolutio… (10.1080/21645515.2018.1462639)
Abstract ORCID License
167.66 171
40 Sustained immunogenicity and efficacy of the HPV-16/18 AS04-… (10.4161/hv.18865)
Abstract ORCID License
165.91 162
41 Plant-derived virus-like particles as vaccines (10.4161/hv.22218)
Abstract ORCID License
165.91 162
42 Vaccination of healthcare workers: A review (10.1080/21645515.2015.1082014)
Abstract ORCID License
164.48 155
43 Interventions to increase HPV vaccination coverage: A system… (10.1080/21645515.2015.1125055)
Abstract ORCID License
164.48 155
44 Misinformation on vaccination: A quantitative analysis of Yo… (10.1080/21645515.2018.1454572)
Abstract ORCID License
164.06 153
45 Coxsackievirus A16 (10.4161/hv.27087)
Abstract ORCID License
163.85 152
46 Global impact of varicella vaccination programs (10.1080/21645515.2018.1546525)
Abstract ORCID License
163.21 149
47 Tumor cell lysates as immunogenic sources for cancer vaccine… (10.4161/21645515.2014.982996)
Abstract ORCID License
163.21 149
48 Induction of mucosal immunity through systemic immunization:… (10.1080/21645515.2015.1114195)
Abstract ORCID License
162.99 148
49 Impact of a physician recommendation and parental immunizati… (10.4161/hv.25823)
Abstract ORCID License
162.99 148
50 <i>In silico</i> design of a DNA-based HIV-1 mul… (10.1080/21645515.2015.1012017)
Abstract ORCID License
162.33 145